251 related articles for article (PubMed ID: 32676765)
21. [The significance of autoantibodies against nodal and paranodal proteins in autoimmune nodopathies].
Ogata H
Rinsho Shinkeigaku; 2023 Nov; 63(11):715-724. PubMed ID: 37880115
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of Anti-Contactin1 Antibody-Associated Autoimmune Nodopathies With Concomitant Membranous Nephropathy.
Xu Q; Liu S; Zhang P; Wang Z; Chang X; Liu Y; Yan J; He R; Luo X; Zou LY; Chu X; Guo Y; Huang S; Fu X; Huang Y
Front Immunol; 2021; 12():759187. PubMed ID: 34675937
[TBL] [Abstract][Full Text] [Related]
23. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
[TBL] [Abstract][Full Text] [Related]
24. Nodal-paranodal antibodies in HIV-immune mediated radiculo-neuropathies: Clinical phenotypes and relevance.
Moodley K; Patel VB; Moodley AA; Bill PLA; Kajee A; Mgbachi V; Fehmi J; Rinaldi S
J Peripher Nerv Syst; 2023 Dec; 28(4):578-585. PubMed ID: 37676746
[TBL] [Abstract][Full Text] [Related]
25. Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy.
Liu L; Chen J; Zhang Y; Wu J; Hu J; Lin Z
Front Immunol; 2022; 13():986018. PubMed ID: 36211443
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
27. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Querol L; Rojas-García R; Diaz-Manera J; Barcena J; Pardo J; Ortega-Moreno A; Sedano MJ; Seró-Ballesteros L; Carvajal A; Ortiz N; Gallardo E; Illa I
Neurol Neuroimmunol Neuroinflamm; 2015 Oct; 2(5):e149. PubMed ID: 26401517
[TBL] [Abstract][Full Text] [Related]
28. Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy.
Briani C; Salvalaggio A; Ruiz M; Cacciavillani M; Rinaldi F; Callegari I; Gasparotti R; Franciotta D
J Neuroimmunol; 2019 May; 330():178-180. PubMed ID: 30713112
[TBL] [Abstract][Full Text] [Related]
29. IgG4 Valency Modulates the Pathogenicity of Anti-Neurofascin-155 IgG4 in Autoimmune Nodopathy.
Jentzer A; Attal A; Roué C; Raymond J; Lleixà C; Illa I; Querol L; Taieb G; Devaux J;
Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35948442
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune nodopathies, an emerging diagnostic category.
Martín-Aguilar L; Lleixà C; Pascual-Goñi E
Curr Opin Neurol; 2022 Oct; 35(5):579-585. PubMed ID: 35989582
[TBL] [Abstract][Full Text] [Related]
31. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ
Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186
[TBL] [Abstract][Full Text] [Related]
32. Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China.
Zhang X; Zheng P; Devaux JJ; Wang Y; Liu C; Li J; Guo S; Song Y; Wang Q; Feng X; Wang Y
J Neuroimmunol; 2019 Dec; 337():577074. PubMed ID: 31693967
[TBL] [Abstract][Full Text] [Related]
33. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
Kira JI
Front Neurol; 2021; 12():665136. PubMed ID: 34177770
[TBL] [Abstract][Full Text] [Related]
34. Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response.
Bresciani L; Salvalaggio A; Vegezzi E; Visentin A; Fortuna A; Anglani M; Cacciavillani M; Masciocchi S; Scaranzin S; Carecchio M; Martinuzzi A; Gastaldi M; Briani C
J Peripher Nerv Syst; 2023 Sep; 28(3):522-527. PubMed ID: 37246762
[TBL] [Abstract][Full Text] [Related]
35. ARTHUR ASBURY LECTURE: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical aspects and new animal models of auto-immunity to nodal components.
Illa I
J Peripher Nerv Syst; 2017 Dec; 22(4):418-424. PubMed ID: 29065233
[TBL] [Abstract][Full Text] [Related]
36. A Systematic Review and Meta-Analysis of Autoantibodies for Diagnosis and Prognosis in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Guo X; Tang L; Huang Q; Tang X
Front Neurosci; 2021; 15():637336. PubMed ID: 34108854
[No Abstract] [Full Text] [Related]
37. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.
Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC
J Neuroimmunol; 2017 Aug; 309():41-46. PubMed ID: 28601286
[TBL] [Abstract][Full Text] [Related]
38. Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.
Tang L; Huang Q; Qin Z; Tang X
J Neurol; 2021 Aug; 268(8):2757-2768. PubMed ID: 32266541
[TBL] [Abstract][Full Text] [Related]
39. Two CIDP Variants Patients With Anti-Caspr1 Antibodies in South China.
Li C; Zheng H; Yuan C; Li Y; Hu Y; Jiang H
Front Immunol; 2022; 13():844036. PubMed ID: 35359983
[TBL] [Abstract][Full Text] [Related]
40. [Autoantibodies in Chronic Inflammatory Demyelinating Polyneuropathy].
Koga M
Brain Nerve; 2018 Apr; 70(4):395-403. PubMed ID: 29632287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
